Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viatris Inc
(NQ:
VTRS
)
11.96
+0.06 (+0.55%)
Streaming Delayed Price
Updated: 11:44 AM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viatris Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, & More
February 06, 2022
Biotech stocks managed to close the week with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid some big pharma earnings. The sector came...
Via
Talk Markets
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
14 Stocks in the Healthcare Sector
January 21, 2022
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%.
Via
Talk Markets
Viatris Recalls One Batch Of Diabetes Treatment Semglee Citing Missing Label Risks
January 20, 2022
Viatris Inc's (NASDAQ: VTRS) Mylan will pull one batch of non-interchangeable Semglee, also known as insulin glargine injection. The Company cited the risk of the...
Via
Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich
Via
InvestorPlace
7 of the Best Cheap Stocks Under $20 for 2022 to Buy Now
January 03, 2022
These cheap stocks are trading at highly attractive prices and have the potential to break through this year.
Via
InvestorPlace
10 Worst Performing S&P 500 Stocks Of 2021
December 31, 2021
The S&P 500 delivered one of its best years in recent history in 2021, gaining more than 27%. Most U.S. investors had a lot of winners in their portfolios this year, but some...
Via
Benzinga
7 of the Best Value Stocks for 2022 to Buy Now
December 15, 2021
Among the best value stocks, these seven provide both deep value and upside potential. Buy now for future gains in 2022.
Via
InvestorPlace
Jim Cramer Shares His Warning On Nio, Expresses Support For TJX And More
December 14, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he doesn’t like NIO Inc. (NYSE:
Via
Benzinga
India's Biocon Mulls Merger Of Biosimilar Business With Mylan: Moneycontrol
December 09, 2021
India-based Biocon Ltd is reportedly in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news website ...
Via
Benzinga
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
December 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.
Via
InvestorPlace
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Biogen Loses Bid To Revive Tecfidera Drug Patent: Bloomberg
November 30, 2021
Biogen Inc (NASDAQ: BIIB) lost its appeals court bid to revive a key patent on the blockbuster multiple sclerosis drug Tecfidera, reports Bloomberg. In a related ruling...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Is It Too Late to Buy Viatris Stock?
November 30, 2021
It's not too late if you're looking for dividend income.
Via
The Motley Fool
7 Stocks 'On Sale' This Holiday Season
November 26, 2021
This time of year, it may feel like you’ve missed out on big rallies in the best stocks. But, there may still be a chance to buy some high-quality stocks for 2022 at a discount to what you would have...
Via
Talk Markets
7 Stocks 'On Sale' This Holiday Season
November 26, 2021
The SPDR S&P 500 ETF Trust (NYSE: SPY) has generated a total return of 26.4% year-to-date, but much of those overall gains have been driven by a handful of megacap stocks. In...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Pharma Stocks That Are Too Cheap to Ignore
November 25, 2021
Many stocks are ridiculously expensive right now -- but not these three.
Via
The Motley Fool
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG...
Via
Benzinga
New Alternatives for Branded Biologics
November 22, 2021
We’ve all heard about generic drugs. They are time-tested and battle-proven medicines that are more affordable than their patented predecessors. Branded drugs consistently...
Via
Benzinga
7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation
November 22, 2021
These companies either have no exposure to inflation or have strong branding and customer loyalty, enabling them to pass higher costs.
Via
InvestorPlace
3 Things About Viatris That Smart Investors Know
November 21, 2021
Don't expect it to follow the trajectory of a hot growth stock.
Via
The Motley Fool
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care
November 12, 2021
Johnson & Johnson will split its consumer health unit into a publicly traded company.
Via
Investor's Business Daily
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Earnings Scheduled For November 8, 2021
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
Could Viatris Stock Help You Retire a Millionaire?
October 23, 2021
It depends on how much help you're looking for.
Via
The Motley Fool
Topics
Retirement
Exposures
Pension
3 No-Brainer Biotech Stocks to Buy Right Now
October 16, 2021
Regeneron Pharmaceuticals, Vertex Pharmaceuticals, and Viatris should have plenty of room to run.
Via
The Motley Fool
2 Ultra-Cheap Stocks Trading Below Their Book Values
October 07, 2021
And these stocks also pay relatively high dividends.
Via
The Motley Fool
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Viatris Inc. and Encourages Investors who Formerly Held Shares of Mylan Inc. (MYL) to Contact the Firm
September 29, 2021
From
The Schall Law Firm
Via
Business Wire
Why Are Theravance Bio Shares Plummeting Premarket Today?
September 15, 2021
Theravance Biopharma Inc (NASDAQ: TBPH) will reduce its headcount by approximately 75% (estimated 270 positions), with most of the lay off to complete in November...
Via
Benzinga
Why Wall Street Thinks This Dirt Cheap Value Stock Could Soar
September 13, 2021
It's kind of a boring stock. But analysts think that it could deliver not-so-boring growth.
Via
The Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.